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A B S T R A C T
Declining fossil fuel reserves, coupled with environmental concerns over their continued extraction and
exploitation have led to strenuous eﬀorts to identify renewable routes to energy and fuels. One attractive option
is to convert glycerol, a by-product of the biodiesel industry, into n-butanol, an industrially important chemical
and potential liquid transportation fuel, using Clostridium pasteurianum. Under certain growth conditions this
Clostridium species has been shown to predominantly produce n-butanol, together with ethanol and 1,3-
propanediol, when grown on glycerol. Further increases in the yields of n-butanol produced by C. pasteurianum
could be accomplished through rational metabolic engineering of the strain. Accordingly, in the current report
we have developed and exempliﬁed a robust tool kit for the metabolic engineering of C. pasteurianum and used
the system to make the ﬁrst reported in-frame deletion mutants of pivotal genes involved in solvent production,
namely hydA (hydrogenase), rex (Redox response regulator) and dhaBCE (glycerol dehydratase). We were, for
the ﬁrst time in C. pasteurianum, able to eliminate 1,3-propanediol synthesis and demonstrate its production
was essential for growth on glycerol as a carbon source. Inactivation of both rex and hydA resulted in increased
n-butanol titres, representing the ﬁrst steps towards improving the utilisation of C. pasteurianum as a chassis
for the industrial production of this important chemical.
1. Introduction
Declining fossil fuel reserves, coupled with environmental concerns
over their continued extraction and exploitation have led to strenuous
eﬀorts to identify renewable routes to energy and fuels. The two most
commonly used biofuels are bioethanol and biodiesel (REN21, 2015).
Between 2004 and 2014 biodiesel production has increased more than
twelvefold, from 2.4 billion litres/year to 29.7 billion litres/year
(REN21, 2015). For every ton of biodiesel produced through the
transesteriﬁcation of vegetable oils and animals fats with short-chain
alcohols (most commonly methanol) 100 kg of crude glycerol (10% [w/
w]), or glycerine, are formed as a by-product. As a consequence,
glycerol availability has increased signiﬁcantly (Johnson and Taconi,
2007; Yang et al., 2012). The glycerol formed is almost always used in
its reﬁned or puriﬁed form to make a multitude of products, including
cosmetics, pharmaceuticals and food and beverages (Quispe et al.,
2013). The glut of glycerine that has resulted from the biodiesel
industry has impacted crude and reﬁned glycerol prices.
Economically, crude glycerol has shifted from by-product to waste-
product (Kerr et al., 2011; Quispe et al., 2013). With the associated
disposal costs, ways to convert crude glycerol into valuable products
are becoming increasingly important (Yazdani and Gonzalez, 2007).
Currently crude glycerol is utilised as a supplement for animal feeds,
reacting agent in chemical catalytic procedures and as a feedstock for
the biological production of chemicals and fuels (Yang et al., 2012). The
high degree of reduction of its carbon atoms (Clomburg and Gonzalez,
2013), its wide availability and low cost have made glycerol an
attractive feedstock for bioreﬁnery (Werpy et al., 2004; Cherubini,
2009; Dobson et al., 2012), especially for anaerobic fermentation
processes (Yazdani and Gonzalez, 2007).
Clostridium pasteurianum is, unlike other well-studied clostridia,
capable of converting glycerol directly into the value-added chemicals
n-butanol and 1,3-propanediol (PDO) (Biebl, 2001; Jensen et al., 2012;
Malaviya et al., 2012). Butanol is an attractive biofuel as it oﬀers a high
energy density, low water solubility, low vapour pressure and good
blending abilities and can be used in regular combustion engines
without the need of modiﬁcation (Dürre, 2007). The organic compound
PDO is used as a precursor for the production of useful polymers such
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as polyesters, polyurethans and polyethers. The polyester polytri-
methylene terephthalate (PTT) accounts for 90.0% of the total PDO
market which is expected to be worth $621.2 million by 2021 (Market
and Market, 2015). It shares many of the features of its polyester
counterpart polybutylene terephthalate (PBT) and polyethylene ter-
ephthalate (PET) but oﬀers higher tensile and ﬂexural strengths and
stiﬀness (Zhang, 2004). In addition, PDO is used in composites,
adhesives, laminates, coatings, moldings, aliphatic polyesters and
antifreeze (Liu et al., 2010).
Under certain growth conditions C. pasteurianum has been shown
(Dabrock et al., 1992; Jensen et al., 2012; Moon et al., 2011; Taconi
et al., 2009) to predominantly produce n-butanol, ethanol and PDO
with trace amounts of organic acids (see Fig. 1). In optimized batch
cultures up to 17 g/l n-butanol have been produced from glycerol, in
pH auxostat cultures around 7 g/l PDO (Biebl, 2001). Recently, a C.
pasteurianum mutant strain was generated producing 17.8 g/l n-
butanol and 8.7 g/l PDO from reﬁned glycerol (Malaviya et al.,
2012). In comparison, engineered C. acetobutylicum and C. beijerinck-
ii mutant strains have been described to produce 18.9 g/l and 20.9 g/l
of butanol (Chen and Blaschek, 1999; Jang et al., 2012). Further
increases in yields of n-butanol produced by C. pasteurianum could be
accomplished through rational metabolic engineering of the strain.
Accordingly, in the present study we have developed the requisite gene
modiﬁcation systems through the implementation of our previously
described roadmap for gene tool development (Minton et al., 2016),
and then used the developed allelic exchange vectors to make in-frame
deletions of spo0A (for exempliﬁcation purposes) and a selection of
mutants likely to aﬀect solvent yields, namely, dhaBCE (encoding
glycerol dehydratase), rex (coding for the redox responsive repressor
Rex) and hydA (encoding an iron-coupled hydrogenase).
2. Methods
2.1. Bacterial strains, growth and maintenance conditions
Bacterial strains used are listed in Table 1. E. coli was grown
aerobically at 30 °C or 37 °C in Luria-Bertani (LB) broth or agar
supplemented with 25 µg/ml chloramphenicol (LBCm25) or 100 µg/ml
kanamycin (LBKm100), respectively. C. pasteurianum was routinely
grown at 37 °C in an anaerobic workstation (Don Whitley, Yorkshire,
UK) in 2x YTG broth (16 g/l tryptone, 10 g/l yeast extract, 5 g/l NaCl,
5 g/l glucose, pH 6.2) or on RCM agar (Oxoid Ltd) supplemented with
15 µg/ml thiamphenicol (2x YTGTm15, RCMTm15), 20 µg/ml erythro-
mycin (2x YTGEm20, RCMEm20) or 40 µg/ml uracil (2x YTGUra40,
RCMUra40), if required. Selections using 5-ﬂuoroorotic acid (FOA,
600 µg/ml; Sigma-Aldrich, Dorset, UK) and uracil (5 µg/ml) were
carried out in modiﬁed clostridial basal medium containing 0.5% (w/
v) CaCO3 and 5% (w/v) glucose (CBM-S) (Steiner et al., 2012) or on
standard clostridial basal medium (CBM) agar (O'Brien and Morris,
1971). All solidiﬁed media contained 1.5% [w/v] agar. Solvent/ acid
proﬁling was undertaken in CGM (Sandoval et al., 2015), Biebl
medium (Biebl, 2001) or 2x YT media supplemented with 60 g/l
glycerol or glucose. Biebl medium was additionally supplemented with
1 g/l yeast extract for glycerol fermentations Table 2.
2.2. Standard molecular biology techniques
Standard plasmids used in this study are detailed in Table 1.
Electroporation of E. coli was carried out using a Gene-Pulsar (Bio-
Rad, Hemel Hempstead, UK) in agreement with the manufacturer's
instructions. Plasmid DNA and genomic DNA was isolated using a
QIAprep spin miniprep or a DNeasy blood and tissue kit (Qiagen,
Manchester, UK), respectively. Restriction digest by endonucleases,
ligation reactions and agarose gel electrophoresis were performed
according to the manufacturer's instructions. Restriction endonu-
cleases were purchased from ThermoFisher Scientiﬁc (Loughborough,
UK) and a LigaFast™ Rapid DNA Ligation kit from Promega
(Southampton, UK). PCR was carried out using the BIO-X-ACT™
Short Mix (Bioline Reagents, London, UK) in accordance with the
manufacturer's instructions. Site-directed mutagenesis (SDM) was
carried out using the Quik Change II Site-Directed Mutagenesis Kit
(Agilent Technologies, Stockport, UK). Oligonucleotides were ordered
from Euroﬁns Genomics (Ebersberg, Germany) and are given in
Supplementary Table S1. Sanger sequencing was carried out by
Source BioSciences (Nottingham, UK). Synthetic DNA fragments were
ordered either from Biomatik (Cambridge, Ontario/Canada) or
GeneArt® Gene Synthesis (Life Technologies, Paisley, UK).
2.3. Plasmid methylation and plasmid transfer into C. pasteurianum
Plasmid DNA for the transformation into C. pasteurianum strain
was in vivo methylated by propagation in the dam+, dcm+ E. coli host
CR1, an E. coli Top10 strain harbouring the plasmid pCR1, comprising
Fig. 1. Central metabolic energy pathway in C. pasteurianum from glucose and glycerol.
Figure based on Malaviya et al. (2012) and Biebl (2001). The knocked out genes (hydA,
dhaBCE) and the NADH/NAD+ utilising pathways putatively inﬂuenced by Rex are
highlighted. Other enzymes involved in the central energy pathway are numbered as
follows: 1, glycerol dehydratase; 2, 1,3-propanediol oxydoreductase. 3, glycerol-3-
phosphate dehydrogenase; 4, dihydroxyacetone kinase; 5, triose-phosphate isomerase;
6, phosphofructokinase; 7, phosphoglucose isomerase; 8, hexokinase; 9, glyceraldehyde-
3-phosphate dehydrogenase; 10, pyruvate kinase; 11, lactate dehydrogenase; 12,
pyruvate-ferredoxin oxidoreductase; 13, ferredoxin-NADP reductase; 14, NADPH-ferre-
doxin oxidoreductase; 15, ferredoxin hydrogenase; 16, phosphate acetyltransferase; 17,
acetate kinase; 18, acetaldehyde dehydrogenase; 19, ethanol dehydrogenase; 20, thiolase;
21, acetoacetyl-CoA: acetate:CoA transferase; 22, acetoacetyl-CoA: butyrate:CoA trans-
ferase; 23, acetoacetate decarboxylase; 24, β -hydroxybutyryl-CoA dehydrogenase; 25,
crotonase; 26, butyryl-CoA dehydrogenase; 27, phosphotransbutyrylase; 28, butyrate
kinase; 29, butaraldehyde dehydrogenase; 30, butanol dehydrogenase.
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a RSF1030-derived RSF origin of replication (Som and Tomizawa,
1982, Novagen, Merck KGaA, Darmstadt, Germany), a kanamycin
resistance marker and a gene encoding the M.BepI methyltransferase
of Brevibacterium epidermidis under the transcriptional control of the
C. sporogenes fdx promoter (PCsp fdx). Alternatively, in vitro methy-
lation was performed by incubation of plasmid DNA with CpG
methyltransferase (M.SssI; NEB, Hitchin, UK), according to the
manufacturer's instructions. Methylated plasmids 0.5–5 μg DNA) were
electroporated into C. pasteurianum as detailed in Supplementary
Information.
2.4. Construction of Allele-Coupled Exchange vectors
All Allele-Coupled Exchange (ACE) vectors generated in this study
were based on the modular plasmid pMTL85151 (Heap et al., 2009)
and conform to previous design principles (Heap et al., 2012). The
pyrE ACE KO vector (pMTL-KS01) used to generate a ΔpyrE mutant
(strain CRG4273) of C. pasteurianum DSM 525 was based on pMTL-
JH12 (Heap et al., 2012). The requisite pyrE KO cassette comprised a
long (1200 bp) right homology arm (RHA) homologous to a region
downstream of pyrE and a short (300 bp) left homology arm (LHA)
composed of an internal portion (nt 35–334) of the pyrE gene (full
details in Supplementary Information). The pyrE ACE correction
(pMTL-AGH12, Fig. 2) and complementation (pMTL-KS12, Fig. 2)
vectors were constructed equivalent to pMTL-YN1/YN2 and pMTL-
YN1C/YN2C (Ng et al., 2013). Plasmid pMTL-AGH12 was generated
through the PCR ampliﬁcation of a 1748-bp fragment comprising the
pyrE nucleotides 35–582 (RHA) and a contiguous region 1200-bp
downstream of its stop codon (LHA) using primers
AGH0001_pyrE_Fw and AGH0001_pyrE_Rev (Supplementary Table
S1) and CRG4111 genomic DNA. Following ampliﬁcation, the DNA
product generated was cleaved with SbfI and AscI, and inserted
between the SbfI and AscI sites of pMTL-KS10 (More information in
Supplementary Information). Plasmid pMTL-KS12 (Fig. 2) was essen-
tially the same as pMTL-AGH12, except in this case the RHA and LHA
were separated by a segment of DNA encompassing a lacZ’-encoding
region containing a MCS region. In contrast to pMTL-YN1C/YN2C,
however, the RHA was followed by a 77-bp fragment encoding the C.
Table 1
Strains and plasmids used in this study. C. pa. = C. pasteurianum.
Name Designation Properties Source
C. pa. ATCC 6013 CRG4080 wild type, type strain ATCC
C. pa. DSM 525 CRG4091 wild type, type strain DSMZ
C. pa. DSM 525-H1 CRG4111 hypertransformable strain based on DSM 525 This study
C. pa. DSM 525-H1ΔpyrE CRG4273 ACE pyrE truncation mutant This study
C. pa. DSM 525-H1ΔpyrEΔspo0A CRG5514 ACE spo0A deletion mutant with ΔpyrE background This study
C. pa. DSM 525-H1Δspo0A CRG5516 ACE spo0A deletion mutant with pyrE repaired This study
C. pa. DSM 525-H1::spo0A* CRG5518 ACE spo0A complementation in pyrE locus This study
C. pa. DSM 525-H1ΔpyrEΔrex CRG5520 ACE rex deletion mutant with ΔpyrE background This study
C. pa. DSM 525-H1Δrex CRG5522 ACE rex deletion mutant with pyrE repaired This study
C. pa. DSM 525-H1::rex* CRG5524 ACE rex complementation in pyrE locus This study
C. pa. DSM 525-H1ΔpyrEΔhydA CRG5526 ACE hyd deletion mutant with ΔpyrE background This study
C. pa. DSM 525-H1ΔhydA CRG5528 ACE hyd deletion mutant with pyrE repaired This study
C. pa. DSM 525-H1::hydA* CRG5530 ACE hyd complementation in pyrE locus This study
C. pa. DSM 525-H1ΔpyrEΔdhaBCE CRG5532 ACE dhaBCE deletion mutant with ΔpyrE background This study
C. pa. DSM 525-H1ΔdhaBCE CRG5534 ACE dhaBCE deletion mutant with pyrE repaired This study
C. pa. DSM 525-H1::dhaBCE* CRG5536 ACE dhaBCE complementation in pyrE locus This study
E. coli Top10 x CR1 CRG3131 Strain harbouring plasmid CR1 With M.BepI methylase This study
pMTL85151 E. coli-Clostridium shuttle vector (pIM13, catP, ColE1 traJ, lacZα ORF/MCS, TCpa fdx) Heap et al.
(2009)
pMTL-AMH101 catP-pyrE module used for pMTL-KS15 Liew et al.
(2017)
pMTL-KS01 pMTL85151, 300-bp internal pyrE fragment, 1200-bp fragment immediately downstream of pyrE This study
pMTL-KS03 pMTL85151, 300-bp internal pyrE fragment, 1200-bp fragment immediately downstream of pyrE, with
TCtet gluRS
This study
pMTL-KS04 pMTL85151, 937-bp fragment immediately downstream of pyrE, 300-bp internal pyrE fragment, TCtet
gluRS, TCpa fdx
This study
pMTL-KS05 pMTL85151, 548-bp internal pyrE fragment, 1200-bp fragment immediately downstream of pyrE This study
pMTL-KS08 pMTL85151, 937-bp fragment immediately downstream of pyrE, 548-bp internal pyrE fragment, TCtet
gluRS, TCpa fdx
This study
pMTL-KS10 pMTL-KS01 features, TCtet gluRS, TCpa fdx, AsiSI This study
pMTL-KS12 pMTL85151, 548-bp internal pyrE fragment, 937-bp fragment immediately downstream of pyrE, TCtet
gluRS, TCpa fdx, AsiSI
This study
pMTL-KS15 pMTL85151, pyrE (C. acetobutylicum), TCtet gluRS, TCpa fdx, 300-bp SHA pyrE, lacZα ORF/MCS This study
pMTL-KS16 pMTL85151, pyrE (C. acetobutylicum), TCtet gluRS, TCpa fdx, AsiSI, 300-bp SHA pyrE, lacZα ORF/
MCS
This study
pMTL-AGH12 1748-bp fragment comprising pyrE (35–582 nt) and 1200-bp immediately downstream of pyrE cloned
into SbfI/AscI recognition sites of pMTL-KS12
This study
pMTL-KS12::spo0A 1095-bp fragment comprising the 267-bp sequence upstream of spo0A and the spo0A gene cloned into
the NotI/NheI recognition sites of pMTL-KS12
This study
pMTL-KS12::rex 816-bp fragment comprising the 183-bp sequence upstream of rex and the rex gene cloned into the
NotI/NheI recognition sites of pMTL-KS12
This study
pMTL-KS12::hyd 2118-bp fragment comprising the 393-bp sequence upstream of hyd and the hyd gene cloned into the
NotI/NheI recognition sites of pMTL-KS12
This study
pMTL-KS12::dhaBCE 2984-bp fragment comprising the 294-bp sequence upstream of dhaB and the dhaBCE genes cloned
into the NotI/NheI recognition sites of pMTL-KS12
This study
pMTL-KS15::KO_spo0A 1400-bp KO out cassette for spo0A This study
pMTL-KS15::KO_rex 1364-bp KO out cassette for rex This study
pMTL-KS16::KO_hyd 2002-bp KO out cassette for hyd This study
pMTL-KS15::KO_dhaBCE 1602-bp KO out cassette for dhaBCE This study
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tetani E88 glutamyl-tRNA synthetase terminator (TCtet gluRS), while
the LHA was preceded by a 42-bp DNA region encompassing the C.
pasteurianum transcriptional terminator of the ferredoxin gene (TCpa
fdx). Full details of the construction of pMTL-KS12 is given in
Supplementary Information.
For the generation of the complementation vectors target genes
including their native promoter were PCR ampliﬁed using CRG4111
genomic DNA as template and a gene speciﬁc oligonucleotide pair (Fw
and Rev) encompassing 5’-NotI and a 3’-NheI recognition sites (see
Supplementary Table S1). Following ampliﬁcation, the DNA fragment
was digested with NotI and NheI, puriﬁed and ligated into appro-
priately cleaved pMTL-KS12. Full details of the construction of the
complementation vectors is given in Supplementary Information.
Table 2
Solvent and acid yields of C. pasteurianum DSM 525 (WT) and its various mutant derivatives when grown in bioreactors on either glucose or glycerol as the carbon source. Mutants
were: C. pasteurianum DSM 525-H1Δrex (Δrex, CRG5522); C. pasteurianum DSM 525-H1Δhyd (Δhyd, CRG5528), and; C. pasteurianum DSM 525-H1ΔdhaBCE (ΔdhaBCE,
CRG5534). Abbreviations used: butanol (BuOH), ethanol (EtOH), 1,3-propanediol (PDO), solvents (EtOH, BuOH, PDO), acids (acetate, butyrate, lactate). Carbon recovery was
calculated by assuming 3.5 g/l dry-weight per 10 OD values (Sarchami et al., 2016), carbon dioxide desorption as described by Percheron et al. (1995) and the assumption that 46.2% of
dry-weight is carbon (Papoutsakis and Meyer, 1985). The carbon fraction of yeast extract was neglected. *Fermentation of ΔdhaBCE was undertaken in serum bottles along with a wild
type control.
Carbon source 60 g/l glycerol 60 g/l glucose
Medium Biebl plus 1 g/l yeast extract 2x YT* Biebl
Strain Δrex Δhyd WT ΔdhaBCE WT Δrex Δhyd ΔdhaBCE WT
Growth characteristics
Specific growth rate [h−1] 0.32 ± 0.04 0.35 ± 0.01 0.42 ± 0.01 0.39 ± 0.00 0.40 ± 0.00 0.15 ± 0.02 0.11 ± 0.01 0.13 ± 0.03 0.16 ± 0.03
Doubling time [min] 135 ± 15 119 ± 3 100 ± 1 106 ± 1 105 ± 0 90 ± 9 103 ± 10 85 ± 4 81 ± 12
Max. OD 15.0 ± 0.5 17.5 ± 0.6 15.3 ± 0.3 4.38 ± 0.12 4.48 ± 0.01 34.9 ± 1.0 36.2 ± 0.1 34.8 ± 2.5 34.3 ± 2.7
Carbon recovery [%] 88.9 ± 2.7 91.4 ± 1.3 90.5 ± 4.4 114.4 ± 6.0 127.8 ± 5.4 70.7 ± 14.3 83.5 ± 15.0 72.3 ± 13.9 73.3 ± 14.9
Selectivity [M/M]
BuOH/Solvents 0.516 ± 0.002 0.312 ± 0.003 0.289 ± 0.024 0.862 ± 0.002 0.795 ± 0.001 0.703 ± 0.015 0.729 ± 0.021 0.635 ± 0.027 0.563 ± 0.051
Yield [M/M]
BuOH/C-Source 0.250 ± 0.005 0.166 ± 0.004 0.142 ± 0.003 0.399 ± 0.019 0.431 ± 0.021 0.124 ± 0.034 0.156 ± 0.029 0.041 ± 0.008 0.031 ± 0.003
EtOH/C-Source 0.053 ± 0.006 0.102 ± 0.001 0.037 ± 0.000 0.064 ± 0.002 0.066 ± 0.003 0.055 ± 0.018 0.061 ± 0.017 0.025 ± 0.007 0.026 ± 0.008
PDO/C-Source 0.182 ± 0.000 0.265 ± 0.005 0.317 ± 0.034 0.000 ± 0.000 0.046 ± 0.002 n.a. n.a. n.a. n.a.
Solvents/C-Source 0.484 ± 0.011 0.533 ± 0.007 0.496 ± 0.030 0.463 ± 0.021 0.542 ± 0.026 0.179 ± 0.052 0.217 ± 0.046 0.066 ± 0.016 0.057 ± 0.001
Acids/C-Source 0.050 ± 0.006 0.106 ± 0.000 0.114 ± 0.008 0.122 ± 0.009 0.136 ± 0.004 0.567 ± 0.129 0.567 ± 0.153 0.686 ± 0.156 0.708 ± 0.177
Fig. 2. Plasmid maps of major plasmids used in this study.
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2.5. Construction of allelic exchange KO vectors
All generated allelic exchange vectors are based on the modular
plasmid pMTL85151 (Heap et al., 2009) designed in accordance with
Ng et al. (2013). For the marker-less, in-frame deletion of genes in
strain CRG4273 (Table 1), the pyrE gene of C. acetobutylicum was
employed as a heterologous counter (negative) selection marker.
Therefore, the catP-pyrE module of the plasmid pMTL-AMH101
(Liew et al., 2017) was cloned as a FseI-PmeI-fragment into the
equivalent sites of pMTL-KS08. The resulting plasmid, pMTL-KS15
(Table 1, Fig. 2), carried strong transcriptional terminators (5’ TCtet
gluRS, 3’ TCpa fdx) that ﬂanked the site of insertion (between SbfI and
NheI) of the KO cassette. Cassettes were generated by SOE (splicing by
overlap extension) PCR as described previously (Ng et al., 2013) and
cloned into pMTL-KS15 via SbfI/NheI sites. Full details of the
construction of AE KO plasmids can be found in Supplementary
Information.
2.6. Allele‐Coupled Exchange procedure
Allele-Coupled Exchange (ACE) vectors were transformed into C.
pasteurianum DSM 525-H1ΔpyrE (CRG4273) and plated onto
RCMTm15 agar. Putative single crossover integrants were identiﬁed as
faster growing, larger colonies (Cartman et al., 2012). These were
restreaked onto RCMTm15 agar and PCR screened for the presence of
single crossovers, using primers KS004_Cpa_pyrE_gen_Fw and
KS007_ 85151_LHA_Rev2 (Supplementary Table S1). In the case of
pyrE KO using pMTL-KS01, clones conﬁrmed as single crossovers
were re-streaked onto CBMFOA600, Ura5 agar plates and incubated for
24- 28 h. Colonies that developed represented putative double cross-
over mutants. These were patch plated onto CBM, CBMTm15U5 and
CBMU5 agar plates to identify double crossover; uracil auxotrophs that
had lost the excised plasmid grow only on the latter media. Deletion
mutants were veriﬁed by Sanger sequencing of the PCR ampliﬁed DNA
fragment generated using the above primer pair.
The procedure was the same for restoration of the pyrE locus to wild
type using the pyrE ACE correction vector (pMTL-AGH12) and the pyrE
ACE complementation vectors (pMTL-KS12) carrying functional copies of
the gene to be complemented, but in this case the faster growing, single
crossover integrants were re-streaked twice onto RCMTm15 agar plates to
purify and incubated for 16- 24 h. Single colonies were then restreaked
onto CBM agar plates, and replica plated onto RCMTm15 agar plates to
check for plasmid loss. Following, successive re-streaking (3- 5 times)
onto fresh CBM and RCMTm15, clones were identiﬁed that exhibited
strong growth on CBM but not on RCMTm15 agar plates. Restoration of
the pyrE locus to WT was conﬁrmed by Sanger sequencing of the DNA
fragment PCR ampliﬁed using primers KS004_Cpa_pyrE_gen_Fw and
KS004_Cpa_pyrE_gen_Rev (Supplementary Table S1).
2.7. Allelic exchange KO procedure
For the construction of speciﬁc gene deletions (spo0A, dhaBCE,
hydA and rex) by allelic exchange, appropriate KO vectors based on
pMTL-KS15 were transformed into the pyrE deletion strain CRG4273
(Table 1) and plated on RCMTm15 agar. Following 48 h incubation,
faster growing colonies were re-streaked twice onto RCMTm15 agar
plates and their identity as single crossover integrants conﬁrmed by
Sanger sequencing of the PCR ampliﬁed DNA fragment using appro-
priate primer pairs. Conﬁrmed single crossover mutants were grown
overnight in 5 ml CBMSFOA600, Ura5 broth to allow the double crossover
to occur, centrifuged (10 min, 8500g, RT) and re-suspended in 250 µl
PBS. A 100 µl aliquot of the suspended cells was serially diluted (up to
10−7) in PBS and 100 µl of each dilution plated onto RCM agar plates.
After a 24 h incubation, 50 single, faster growing colonies were selected
and re-streaked in the indicated order onto RCMTm15, CBM and RCM
agar plates. Colonies, which lost the plasmid and either reverted back
to the WT or carried the desired deletion exhibited no growth on
RCMTm15 and CBM agar plates but grew on RCM agar plates. These re-
streaks were subjected to colony PCR, using gene speciﬁc primers that
ﬂanked the intended deletion, and the ampliﬁed DNA fragment
subjected to Sanger sequencing to conﬁrm the expected genotype.
The pyrE deletion of veriﬁed mutants was restored to WT using the
ACE plasmid pMTL-AGH12 (Fig. 2).
2.8. Next-generation sequencing and resequencing analysis
Illumina sequencing of genomic DNA was done by the Deep Seq:
Next Generation Sequencing Facility (University of Nottingham, UK)
using a MiSeq Illumina system (Illumina, USA). Paired-end reads were
mapped against the published C. pasteurianum DSM 525 (strain
CRG4091) genome (Poehlein et al., 2015) CLC Genomics Workbench
8.0.2 (Qiagen, DK). Single nucleotide polymorphisms (SNPs) were
analysed using the basic variant caller in CLC Genomics Workbench
8.0.2 (Qiagen, DK).
2.9. Fermentation in serum ﬂasks
To analyse butanol production, strains were grown either in 50 ml
CGM (Sandoval et al., 2015), Biebl medium (Biebl, 2001) or 2x YTG
broth in serum bottles at 37 °C with a starting pH of 6.2. Media was
supplemented with 60 g/l glucose or glycerol as carbon source. Biebl
medium was additionally supplemented with 1 g/l yeast extract for
glycerol fermentations. Cultures were initiated in an anaerobic work-
station (Don Whitley, Yorkshire, UK) by inoculating and re-suspending
several colonies from CBM agar plates into 10 ml CGM, Biebl or 2x
YTG broth containing 60 g/l glucose. After overnight incubation, 1 ml
of culture was used to inoculate 20 ml CGM or 2x YTG or 35 ml Biebl
broth supplemented with 60 g/l glucose or glycerol and incubated for
6 h prior to diluting up to 10−3 and incubating in fresh media and
growing overnight. Those cultures that were in mid-exponential phase
were used to inoculate 50 ml CGM, Biebl or 2x YTG broth supple-
mented with 60 g/l glucose or glycerol to a starting OD600 of 0.05
(CGM, 2x YTG, Bieblglucose) or 0.075 (Bieblglycerol). At this point, serum
bottles were removed from the anaerobic workstation and incubated
37 °C for up to 48 h. The OD600 and pH were monitored and samples
for product analysis taken every 3 h initially then at 24 h and close to
the end of fermentation. All culturing was carried out in triplicate.
2.10. pH-controlled batch fermentation
To enable optimum butanol production, pH-controlled batch
fermentations were carried out in a Multifors 2 parallel reactor system
(Infors UK, Reigate, UK) containing 350 ml Biebl broth supplemented
with 60g/l glucose or glycerol and 1g/l yeast extract were incubated at
37 °C, 250 rpm and continuous sparging with sterile N2 (1 l/min). The
initial pH of the medium was 6.0. Following inoculation the pH was
held above 6.0 by the automatic addition of 4 M KOH. Pre-cultures
were grown as described above for the serum ﬂask fermentation, with
the exception, that the volume of the ﬁnal 16 h dilution series was
35 ml. The main fermentation broth was inoculated to a starting OD600
of 0.75. Batch fermentations were run for 48 h. Growth was monitored
through online optical density (OD) as well as through the external
measurement of triplicate samples employing a BioMate 3 spectro-
photometer (Thermo Fisher Scientiﬁc, Loughborough, UK). Samples
for solvent analysis were taken at the same time. Additionally the pH,
redox potential and temperature of the culture broth were monitored
online.
To enable optimum sporulation, pH-controlled batch fermentations
were carried out at 37 °C, 200 rpm, with continuous sparging of sterile
N2 (0.02 ml/ml) in the same Multifors 2 parallel reactor system (Infors
UK, Reigate, UK) containing 400 ml of CBM broth comprising no
CaCO3 but 6% (w/v) glucose. To set up the pH-controlled batch
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fermentation, the strain of interest was streaked from -80 °C stocks
onto RCM agar plates, incubated overnight at 37 °C and subsequently
used to inoculate 10 ml CBM-S broth containing 6% (w/v) glucose. The
10 ml culture was grown overnight and used to inoculate 50 ml CBM-S
broth at a 2% (v/v) inoculum. A 50 ml aliquot of this pre-culture was
used to start the pH-controlled batch culture at an inoculum of 6.5%
(v/v). The pH was allowed to drop from 6.5 to 5.5, before being
maintained at 5.5 by the addition of 4 M KOH. Batch fermentations
were run for 120 h.
2.11. Spore assay
Spore assays were carried out either in ﬂasks for a quick screen or
in pH controlled batch cultures (see Section 2.10) to enable eﬃcient
sporulation. In ﬂasks, 200 ml CBM-S broth supplemented with
0.25 mM phosphate buﬀer (pH 7.3, Steiner et al., 2012) were inocu-
lated from CBM-S overnight culture to a ﬁnal OD600 of 0.1 and grown
anaerobically for 120 h at 37 °C. After incubation cultures were shaken
thoroughly and 100 µl samples taken in duplicate to be treated at 80 °C
for 10 min and plated on RCM agar plates to quantify the number of
heat resistant colony forming units (CFUs) per ml. pH-controlled (5.5)
batch cultures were grown for 120 h. Cells were normalized to the
lowest OD600 in a ﬁnal volume of 5 ml PBS buﬀer, centrifuged (10 min,
10,000g, 4 °C), re-suspended in 200 µl PBS buﬀer and heated to 80 °C
for 30 min. Serial dilutions in a total volume of 1 ml PBS were carried
out and 10 µl aliquots were spotted onto RCM agar plates. The plates
were incubated for 24 h at 37 °C before colonies were enumerated. The
sporulation eﬃciency was determined as number of heat-resistant
CFU/ml of culture, that germinate and grow. All results were conﬁrmed
microscopically.
2.12. HPLC analysis of glycerol, glucose and metabolites
Samples (2 ml) of C. pasteurianum cultures from bottle fermenta-
tions were collected, centrifuged (10 min, 16,000g, 4 °C) and cell-free
supernatants stored at -80 °C until analysed. Cell-free supernatants
were thawed on ice, mixed with an equal volume (200 µl) of internal
standard solution (80 mM valeric acid [Sigma-Aldrich, Dorset, UK] in
0.005 M H2SO4), ﬁltered through a 0.22 µm HPLC certiﬁed syringe
ﬁlter (Whatman® Spartan® 13/0.2 RC; GE Healthcare Life Sciences,
Little Chalfont, UK) and transferred into a HPLC vial with a 100 µl
insert. Substrate (glucose, glycerol) and fermentation products (acet-
ate, acetone, butanol, butyrate, lactate, ethanol, PDO) were analysed by
the use of a Dionex UltiMate 3000 HPLC system (Thermo Fisher
Scientiﬁc, Loughborough, UK) equipped with a Bio-Rad Aminex HPX-
87H (Hertfordshire, UK) column, a refractive index (RI) and diode
array detector (DAD) at UV 210 nm at an isocratic ﬂow rate of 0.5 ml/
min of 0.005 M H2SO4 as mobile phase and a column temperature of
35 °C for 55 min. The injection volume was 20 µl. If required samples
were diluted using reverse osmosis (RO) water. Standard concentra-
tions ranged from 0.98 to 250 mM. For glycerol two additional
concentrations of 500 mM and 750 mM were employed. Signal analysis
was performed using the Chromeleon 7.2 Chromatography Data
System (Thermo Fisher Scientiﬁc, Loughborough, UK). Statistical
analysis of signiﬁcance was performed using the PRISM (GraphPad
Software, La Jolla, USA) employing Fisher's t-test. The signiﬁcance
level (α-value) was set at 0.05.
2.13. Identiﬁcation of putative Rex boxes in C. pasteurianum
The C. pasteurianum genome was analysed for the presence of Rex
binding boxes using the Rex box consensus sequence (5’-
TTGTTAANNNNTTAACAA) reported by Ravcheev et al. (2012) with
the ’Virtual Footprint’ algorithm (Münch et al., 2005) allowing 2
mismatches in a similar fashion to Wietzke and Bahl (2012). As the
C. pasteurianum genome was not available in the PRODORIC database
(Münch et al., 2003) to which ’Virtual Footprint’ is linked, the results
were analysed manually. Each ‘hit’ was searched against the genome of
C. pasteurianum DSM 525 (Poehlein et al., 2015) using the Artemis
genome browser (Rutherford et al., 2000). The information extracted
was the locus tag, gene name if applicable, protein function and
location of the target sequence in respect of the genome context.
Only target regions in intergenic regions with a putatively regulated
gene up- or downstream were considered. For every entry in the list the
distance to the closest start codon was measured and a frequency plot
with a bin size of 10 bp was considered. The result is a positive skewed
distribution with the maximal target site occurrence between 80 bp and
90 bp from the start codon which dropped to near zero occurrences
after 250 bp from the start codon. This observation led to further
ﬁltering the list with a threshold of 250 bp distance to the start codon.
The resulting list comprised 40 sequences which were used in an
iterative approach to run ’Virtual Footprint’ with a new Position Weight
Matrix (PWM). This led to a list of 113 targets which were ﬁltered to
exclude hits in coding regions of genes and in intergenic regions with
antidromic genes. The ﬁnal list comprised 47 targets which putatively
regulate downstream genes (Supplementary Table S2).
3. Results
3.1. Improved transformation of C. pasteurianum DSM 525
C. pasteurianum ATCC 6013 has been shown to be transformable
with several pMTL80000 modular vectors (Heap et al., 2009) at
eﬃciencies of up to 7.5×104 transformants μg-1 DNA (Pyne et al.,
2013). This high frequency was reliant on circumventing the activity of
the endogenous CpaAII restriction-modiﬁcation system by in vivo
methylation of its recognition site (5’-CGCG-3’) using the M.FnuDII
methyltransferase (Pyne et al., 2013). As the E.coli host employed
(Top10) was dam+, the activity of the restriction enzyme CpaII, a
MboI/DpnII-type restriction endonuclease previously identiﬁed as
CpaI (Richards et al., 1988), was of no consequence. Here we used
either in vitro or in vivomethylation by M.SssI or M.BepI, respectively.
The former methylates all cytosine residues within the double-stranded
recognition site 5’-mCG-3’ (Renbaum et al., 1990), whereas similar to
M.FnuDII, M.BepI methylates the external cytosine (5’-mCGCG-3’) of
the CpaAII recognition site (Lunnen et al., 1988). Whilst either
methylation procedure allowed transformation of both ATCC 6013
and DSM 525 (equivalent to ATCC 6013) to be obtained with plasmids
pMTL83151 (pCB102 replicon) and pMTL85151 (pIM13 replicon)
(Heap et al., 2009) using our published method (Cooksley et al., 2012),
the success rate and frequencies obtained was very low, 1.5×101
transformants μg-1 DNA. After adapting the method published by
Pyne et al. (2013) with added sucrose in growth medium and extra step
of glycine wash, the transformation frequency was improved to 1.6×102
transformants μg-1 DNA, still two orders of magnitude lower than
reported by Pyne et al. (2013) of which up to 7.5×104 transformants
μg-1 DNA was achieved. Plasmids pMTL82151 (pBP1 replicon) and
pMTL84151 (pCD6 replicon) could not be transformed.
We hypothesised that one reason for the low number of transfor-
mants was that those cells that were competent for the acquisition of
plasmid DNA represented rare mutant cells present within the
population. This hypothesis was tested by curing the plasmid of a
randomly selected transformant of DSM 525 through repeated sub-
culture in the absence of the selective antibiotic, and then retesting the
cured strain to see if the plasmid-free strain was more amenable to
electroporation. The strain was found to transform at frequencies of
2.6×105 transformants μg-1 DNA. Moreover, similar frequencies were
observed with plasmids pMTL85151, pMTL82151 and pMTL84151
(Heap et al., 2009). Whole genome sequencing of the strain with higher
frequency C. pasteurianum DSM 525-H1 (designated CRG4111) and
compared to the parental strain C. pasteurianum DSM 525 (Poehlein
et al., 2015) indicated that two SNPs had arisen within two distinct
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open reading frames, that of CLPA_c13710 and CLPA_c33080
(Poehlein et al., 2015). Unexpectedly, neither encoded protein was
obviously associated with restriction/ modiﬁcation. Both SNPs resulted
in frame-shifts in the encoded sequence. CLPA_c13710 encodes a
predicted β-lysine N6-acetyltransferase (ablB) which was reduced from
283 amino acids to 176 residues in the hypertransformable mutant.
CLPA_c33080 encoded a histidine kinase (ResE9) and leads to a
frameshift that reduces the protein from 615 to 160 amino acids in
length. To ascertain whether the general phenotypic properties of the
CRG4111 mutant strain had been aﬀected by the SNPs, comparative
growth experiments were performed on glycerol as the carbon source.
The growth and glycerol consumption rates of the mutant were similar
to the parental strain. Aside from a small increase in the levels of PDO
and a small reduction in n-butanol, all other measured metabolites
(ethanol, lactate, acetate and butyrate) were essentially the same
between the two strains. On this basis, the strain was taken forward
for metabolic engineering studies.
3.2. Implementation of a gene system roadmap
We have previously described the implementation of allelic ex-
change, gene KO systems in speciﬁcally generated pyrE mutants of
Clostridium acetobutylicum (Ehsaan et al., 2016) and Clostridium
diﬃcile (Ng et al., 2013), and most recently Geobacillus thermogluco-
sidasius (Sheng et al., 2017). The generation of mutants by allelic
exchange is facilitated by the use of replication defective, or pseudo-
suicide vectors (Cartman and Minton, 2010), and the incorporation
into the vector of a functional copy of a heterologous pyrE gene
(encoding orotate phosphoribosyl transferase) that serves as a counter/
negative selection marker. This approach serves as a general roadmap
for the implementation of gene KO systems in clostridia (Minton et al.,
2016). Pivotal are the generation of a pyrE truncation mutant using
Allele-Coupled Exchange (ACE) technology (Heap et al., 2012) and the
identiﬁcation of an appropriately replication defective (pseudo-suicide)
vector.
Segregation stability studies (see Supplementary Information) on
transformed cells carrying the various pMTL80000 modular vectors
established that plasmids based on the pIM13 replicon were suitably
defective, with 99% of the cells losing the plasmid after eight 12 h
subcultures (approximately 51 generations) in media lacking antibiotic
selection. Accordingly, a pIM13-based vector (pMTL-KS01) was con-
structed (Fig. 2 and Materials and Methods) equivalent to the ACE
plasmids pMTL-YN18 (Ng et al., 2013) and pMTL-JH12 (Heap et al.,
2012) and a pyrE (CLPA_c26850) truncation mutant generated as
previously described (Heap et al., 2012; Ng et al., 2013). In essence,
thiamphenicol (Tm) resistant (R) transformants in which pMTL-KS01
had integrated into the CRG4111 genome via a longer Right Homology
Arm (RHA) were identiﬁed as larger, faster growing colonies on RCM
media supplemented with 15 µg/ml Tm (RCMTm15) and puriﬁed by
restreaking onto the same selective media. Of the 24 selected colonies,
all were shown to be pure single crossover mutants through PCR
screening using appropriate primers (see Supplementary Table S1). To
select for a subsequent double crossover excision event involving the
shorter Left Homology Arm (LHA) and the generation of the required
5-ﬂuoroorotic acid (FOA), resistant pyrE deletion mutant, single
crossover integrants were restreaked onto CBM media supplemented
with 5 µg/ml uracil (Ura) and FOA at the experimentally determined
MIC (600 µg/ml) of the parental strain (CBMUra5, FOA600). From a total
of eight FOAR clones obtained, subsequent restreaking and testing of
phenotype on appropriately supplemented media demonstrated that in
addition to being FOAR, three were uracil auxotrophs (required
supplementation of CBM media with exogenous uracil for growth)
and sensitive (S) to Tm (could not grow if Tm was present). From PCR
screening using primers ﬂanking the pyrE gene and the subsequent
sequencing of the ampliﬁed DNA fragment, two of the three clones
were shown to carry the desired modiﬁcation. This equated to a
deletion extending from nt 335–582 of CLPA c26850, and the
concomitant insertion of the lacZα/MCS originating from pMTL-
KS01. One strain was selected for further use and designated
CRG4273. To demonstrate that CRG4273 could be restored to wildtype
(WT) through correction of the pyrE allele an ACE, pyrE repair vector
was made (pMTL-AGH12) equivalent to pMTL-YN1/2 (Ng et al., 2013)
and pMTL-ME6 (Ehsaan et al., 2016) (see Fig. 2). The region of
homologous DNA in this plasmid essentially comprises a contiguous
region of DNA from the pyrE locus that includes a complete copy of the
pyrE gene and downstream region equivalent to the 1200 bp RHA of
plasmid pMTL-KS01. This plasmid was transformed into CRG4273
and single crossover integrants identiﬁed as larger, faster growing
colonies on CBMTm15, Ura5 agar plates. Growth from several represen-
tative colonies were thereafter restreaked onto CBM agar lacking any
supplementation, and single colonies patch plated onto RCM
and RCMTm15 agar plates to identify those clones in which the
excised plasmid had been lost. The pyrE locus of three
representative clones was ampliﬁed by PCR using appropriate PCR
primers (KS004_Cpa_pyrE_gen_Fw and KS004_Cpa_pyrE_gen_Rev,
Supplementary Table S1) and subjected to Sanger sequencing. This
data conﬁrmed that the locus had been restored to WT in all three
cases. One was chosen for storage and designated CRG5570 (Table 1).
3.3. Exempliﬁcation of the knock-out vector pMTL-KS15
The availability of the pyrE deletion mutant CRG4273 is a
prerequisite for the use of a functional heterologous pyrE gene as a
counter selection marker in gene knock-out (KO) by allelic exchange.
Accordingly, a KO vector broadly equivalent to pMTL-YN3/4 (Ng et al.,
2013), pMTL-ME3 (Ehsaan et al., 2016) and was made, pMTL-KS15
(Fig. 2), and exempliﬁed through the in-frame deletion of the master
regulator of sporulation, spo0A. Precise details of the vector are given
in Materials and Methods, but is essentially based on the pIM13
replicon and incorporates the C. perfringens catP selectable marker
and a heterologous pyrE gene derived from C. acetobutylicum (Liew
et al., 2017), as opposed to the C. sporogenes pyrE gene used in the
previous studies (Ehsaan et al., 2016; Ng et al., 2013).
The KO cassette for spo0A (CLPA c19180) was generated by SOE PCR
as described in Materials and Methods and cloned between the SbfI and
NheI sites of pMTL-KS15. Following transformation of the resultant
plasmid (pMTL-KS15::spo0A, Table 1) into CRG4273 and plating on
RCMTm15 agar plates, putative single crossover integrants were identiﬁed
as faster growing, larger colonies. Their identity as pure single crossover
integrants was conﬁrmed by appropriate PCR (primers
KS005_spo0A_genome_Fw, KS005_rex_genome_Rev, Supplementary`
Table S1) and then one of the twelve identiﬁed grown overnight in
CBMSFOA600, Ura5 broth to allow the double crossover event to take place.
After the overnight incubation the culture was centrifuged, re-suspended
and serial dilutions plated to single colonies on RCM agar plates. Selected
colonies were patch plated onto RCMTm15 and un-supplemented RCM
agar plates and onto CBM media lacking uracil. Growth on RCM
alone conﬁrmed loss of the plasmid, and the encoded catP and
pyrE genes, following its excision. PCR screening with ﬂanking
primers (KS005_spo0A_genome_Fw and KS005_spo0A_genome_Rev,
Supplementary Table S1), was then used to distinguish between those
excision events that had generated the desired deletion as opposed to
return of the cell to WT. A total of 17 of the 50 putative KO clones
screened generated a smaller DNA fragment consistent with the intended
deletion in spo0A (Supplementary Fig. S1). Through Sanger sequencing
of the ampliﬁed DNA fragment, the presence of the expected spo0A
deletion was conﬁrmed in all 17 strains. One of the clones was selected
(CRG5514) and restored to uracil prototrophy using the ACE vector
pMTL-AGH12 as previously described. The ﬁnal strain, carrying only the
spo0A mutation, was designated CRG5516. In parallel, a derivative of
pMTL-KS12 was constructed (pMTL-KS12::spo0A*, Table 1) in which a
functional copy of the C. pasteurianum spo0A gene, together with its
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native promoter, was inserted into the MCS between the LHA and RHA.
Use of this strain to restore the pyrE mutation of CRG5514 to WT led to
insertion of spo0A into the chromosome for complementation studies.
The genotype of the strain generated, CRG5518, was conﬁrmed by PCR
ampliﬁcation of the pyrE locus and inserted spo0A gene and nucleotide
sequencing of the DNA fragment ampliﬁed.
3.4. Phenotypic analysis of spo0A deletion mutant
As expected, after 5 days of growth in a pH-controlled batch
cultures (pH 5.5), no heat resistant CFUs were obtained after plating
on RCM of the spo0A mutant strain CRG5516. In contrast, cultures of
the WT (CRG4111) and the complemented mutant strain CRG5518
yielded 1×108 heat resistant CFU/ml. In keeping with these measure-
ments, spores were easily detected using phase contrast microscopy in
the cell suspensions of CRG4111 (parent) and CRG5518 (spo0A,
complemented), whereas none could be detected in cultures of
CRG5514 (spo0A) (Fig. 3a). To analyse the eﬀects of the spo0A
deletion on solvent proﬁles, strains CRG4111 (parent), CRG5516
(spo0A) and CRG5518 (spo0A, complemented) were grown in 50 ml
Biebl medium supplemented with 60 g/l glycerol (Fig. 3b). All strains
exhibited a similar growth rate but the pH of the spo0A mutant
(CRG5516) dropped to a lower level than the parent and complemen-
ted strain, presumably due to increased production of lactate and
butyrate. Glycerol uptake, acetate production and reassimilation and
ethanol production are similar in all strains.
Butanol and PDO levels were slightly lower in the mutant in Biebl
medium. In contrast, the complemented spo0A mutant strain
(CRG5518) produced slightly higher levels of these solvents. The data
obtained was at some variance from that of Sandoval et al. (2015) who
undertook a similar analysis of a spo0A mutant of C. pasteurianum.
However, these authors used rich media (CGM) as opposed to the
minimal media employed here. We, therefore, repeated our analysis
using CGM (Fig. 3c). In this medium, the production of lactate and
butyrate by the spo0A mutant was signiﬁcantly increased compared to
the parent strain, CRG4111. Interestingly, the mutant (CRG5516)
produced much more acetate in the initial stages of the fermentation,
but then reassimilated the acid from 12 h onwards. No equivalent
reassimilation was seen in either the parental (CRG4111) or comple-
mented (CRG5518) cultures. In common with the observations of
Sandoval et al. (2015), compared to the parental strain (CRG4111),
glycerol consumption was signiﬁcantly increased together with the
production of higher levels of n-butanol. In contrast to Sandoval et al.
(2015), however, the PDO levels of the spo0A mutant (CRG5516) were
not reduced compared to the wildtype but remained unaltered.
3.5. Construction of deletion mutants in genes involved in solvent
production
To investigate whether solvent proﬁles could be altered in favour of
n-butanol production we targeted genes encoding the redox-responsive
regulator Rex, the main hydrogenase (hydA) and the glycerol dehy-
dratase (dhaBCE).
Rex has been previously shown to control the expression of n-
butanol biosynthetic genes in response to the cellular NADH/NAD+
ratio in C. acetobutylicum where its disruption led to reduced acid
production and increased solvents yields (Wietzke and Bahl, 2012). In
C. acetobutylicum the rex gene resides immediately 5’ to the crt-bcd-
etfAB-hbd operon responsible for butyryl-CoA biosynthesis (Wietzke
and Bahl, 2012). An equivalent gene (CLPA_c28640) is found in the
same context in C. pasteurianum and encodes a 213 amino acid
protein exhibiting 76% amino acid sequence identity to the C.
acetobutylicum Rex. In the case of hydrogenase, a number of diﬀerent
[FeFe]-hydrogenases and [NiFe]-hydrogenase exist in C. pasteurianum
but little information is available concerning their speciﬁc individual
roles in hydrogen formation and redox balance. BLAST analysis
showed that the protein encoded by CLPA_c00280 exhibits 71%
identity to the well described C. acetobutylicum hydrogenase, hydA
(Santangelo et al., 1995). Accordingly, KO cassettes to bring about the
deletion of CLPA_c28640 (Rex) and CLPA_c00280 (Hyd) were gener-
ated by SOE PCR, cloned into pMTL-KS15 and the resultant mutants
generated by allelic exchange using our standard procedure (Table 1,
Supplementary Fig. S1 and Materials and Methods).
Simplistically, one way to increase butanol titres when growing on
glycerol might be to eliminate PDO production. The conversion of
glycerol to PDO involves a two-step transformation by glycerol
dehydratase (DhaBCE), encoded by dhaBCE (CLPA_c22770-
CLPA_c22760-CLPA_c22750) and PDO dehydrogenase (DhaT), en-
coded by dhaT (CLPA_c22740). Given the inability of Pyne et al.
(2016) to isolate a clean mutant of dhaT in the presence of the toxic
intermediate 3-hydroxypropionaldehyde (3-HPA) (Barbirato et al.,
1996; Maervoet et al., 2014), we chose to ablate PDO production by
eliminating the synthesis of glycerol dehydratase through deletion of
the entire dhaBCE operon. Accordingly, a KO cassette to achieve this
was generated by SOE PCR, cloned into pMTL-KS15 and the resultant
KO plasmid used to generate a dhaBCE mutant (CRG5532) by allelic
exchange using our standard procedure (Table 1, Supplementary Fig.
S1 and Materials and Methods).
In all three cases (rex, hyd and dhaBCE), the mutants were restored
to uracil prototrophy, through ACE-mediated correction of the pyrE
mutation, and complemented through the integration of a functional
Fig. 3. Comparison of sporulation and fermentation phenotypes of C. pasteurianum-H1
(H1), C. pasteurianum-H1Δspo0A (Δspo0A) and C. pasteurianum-H1-spo0A comple-
mentation (spo0A*). a) Spores can be observed in H1 and spo0A* whereas Δspo0A as
expected is incapable of producing spores. b), c) Pure glycerol fermentation in serum
bottles with 60 g/l glycerol in Biebl medium (b) and CGM (c) was carried out for 48 h
with fermentation being visibly completed after 24 h which is the time point shown for
glucose consumption and product formation. * indicate statistical signiﬁcance in t-test α
> 0.05 of deletion or complementation strain against H1. Error-bars indicate standard
error of three replicates.
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copy of the deleted gene with the native promoter concomitant with
restoration of the mutant pyrE allele to WT (Materials and Methods).
Phenotypic analysis of all mutants, and their complemented equiva-
lents, involved the determination of carbon utilisation as well as the
concentration of the following fermentation products: acetate, buty-
rate, lactate, acetone, ethanol, PDO and n-butanol. All studies, with the
exception of the glycerol fermentation of the dhaBCE mutant
(CRG5534), were carried out in batch culture in bioreactors using
Biebl medium supplemented with 1 g/l yeast extract and 6% (w/v)
glycerol or with glucose omitting yeast extract. Fermentation proﬁles
are shown in Figs. 4–6.
3.6. Phenotypic analysis of the rex and hyd mutants
In glycerol media (Fig. 4), both mutants grew at broadly equivalent
growth rates compared to the WT, but achieved higher ﬁnal pH values,
being 8.7 ± 0.2 and 7.5 ± 0.1 after 48 h for the hydA and rex mutant,
respectively compared to 6.6 ± 0.3 in the WT culture. Almost complete
glycerol consumption took place in the WT and hydA culture (2% and
7% remaining, respectively), with the rex mutant culture containing
20% after 48 h. The hydA mutant produced the highest titres of both
lactate and acetate, but signiﬁcantly reduced amounts of butyrate. A
slightly greater reduction in butyrate production was observed with the
rex mutant compared to the hydA mutant. In terms of lactate and
acetate production, the former were slightly increased compared to the
WT, whereas the latter marginally decreased. In the case of solvents,
PDO production was reduced in both mutants, with the largest
reduction occurring in the rex mutant, which decreased by 53%
compared to the WT, with only a 19% reduction being evident in the
hydA mutant. Ethanol formation in the hydA mutant was signiﬁcantly
elevated (64.3 ± 3.2 mM after 24 h) over both the WT and rex mutant
which, with respective titres of 24.2 ± 1.4 mM and 28.0 ± 3.2 mM, were
broadly equivalent. Butanol formation was highest in the rex mutant,
with the titres achieved after 24 h being 133.3 ± 1.8 mM compared to
105.1 ± 0.0 mM in the hydA mutant and 93.2 ± 5 mM in the WT. After
24 h the ethanol and butanol levels decreased, most likely due to
solvent extraction by gas stripping from the nitrogen bubbling through
the reactor.
On glucose (Fig. 5), the growth rate and glucose utilisation rates
were little aﬀected in either mutant compared to the WT. Diﬀerences in
acid production were also less marked in the two mutants compared to
when grown on glycerol. Acetate production in the hydA mutant was
slightly increased compared to the WT and rex mutant, which were
essentially the same. On the other hand, lactate production in the hydA
Fig. 4. Pure glycerol fermentations of C. pasteurianum-H1 (H1), C. pasteurianum-H1Δrex (Δrex), C. pasteurianum-H1-rex complementation (rex*), C. pasteurianum-H1Δhyd (Δhyd)
and C. pasteurianum-H1-hyd complementation (hyd*). a) Bioreactor fermentation with 60 g/l glycerol in Biebl medium with 1 g/l yeast extract at pH 6 was carried out for 48 h with
fermentation being visibly completed after 24 h. Error-bars indicate range of two fermentations. b) Histogram showing product formation of serum bottle fermentation of deletion
strains and complementations. Glycerol usage and product formation is shown after 24 h. * indicate statistical signiﬁcance in a t-test α > 0.05 of deletion or complementation strain
against H1. Error-bars indicate standard error of three replicates.
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mutant was only slightly reduced compared to the rex mutant and WT.
Butyrate produced was decreased in both mutants compared to the
WT, with the larger reduction being seen in the hydA mutant,
producing 57.0 ± 14.3 mM compared to 115.0 ± 30.0 mM in WT cul-
ture after 24 h. Ethanol and n-butanol titres, and in particular the latter
solvent, were increased in both mutants, with hydA demonstrating a
2.3-fold and 5-fold higher ﬁnal titre than the WT, respectively, at 24 h.
Whilst the fermentation proﬁle of the complemented hydA mutant
was essentially restored to that of the WT, complementation of the rex
mutant was less clear cut. Thus, whereas the PDO levels of the mutant
were reduced in comparison to the WT and the n-butanol levels
increased, the complemented strain produced higher amounts of
PDO and reduced titres of n-butanol, relative to the WT. Such a
phenotype would be indicative of higher than normal expression of rex
in the complemented strain, however, the rex gene was inserted at
pyrE under the control of its native promoter. In certain instances
expression of genes can be aﬀected by the proximity of the gene to the
origin of chromosome replication (Sauer et al., 2016). This does not
appear to be the case here, as the distance of rex and pyrE to the origin
are relatively similar with rex being slightly further away from the
origin. In C. kluyveri, rex is self-regulated through the agency of a Rex
box, repressor site immediately upstream of the structural gene (Hu
et al., 2016). Whilst such an operator site was not evident in the C.
pasteurianum rex promoter region used to express the complementing
copy of rex, a Rex box was found 340 bp upstream of the rex start
codon within the upstream CLPA_c28650 gene (genome position
3068768- 3068786). As the promoter region used in the complemented
strain lacks this sequence it is likely that rex expression is deregulated,
resulting in the observed produced higher amounts of PDO and
reduced titres of n-butanol, relative to the WT.
3.7. Phenotypic analysis of the dhaBCE mutant
Growth of C. pasteurianum on glycerol is not redox balanced
because cell biomass (_D, 4.3) is more oxidised than glycerol (_D,
4.67). The requirement to oxidise the excess of reducing equivalents
generated is met by the PDO pathway which ensures the net oxidation
of 1 mol of NADH per 1 mol of PDO formed. The central role of this
pathway in maintaining redox balance suggests that the imbalance
caused by its inactivation in C. pasteurianum would lead to an inability
to ferment glycerol. Indeed, the mutant (CRG5534) was unable to grow
in a bioreactor in Biebl medium when the carbon source was 6% (w/v)
glycerol. The mutant was, however, able to grow in 2x YT containing
glycerol (6%, w/v) at equivalent rates to the WT (Fig. 6). The most
notable change in fermentation proﬁle was the production of PDO,
which, as expected, was eliminated in the mutant (Fig. 6). In contrast,
Fig. 5. Glucose fermentations of C. pasteurianum-H1 (H1), C. pasteurianum-H1Δrex (Δrex), C. pasteurianum-H1-rex complementation (rex*), C. pasteurianum-H1Δhyd (Δhyd) and
C. pasteurianum-H1-hyd complementation (hyd*). a) Bioreactor fermentation with 60 g/l glucose in Biebl medium at pH 6 was carried out for 48 h with fermentation being visibly
completed after 24 h. Error-bars indicate range of two fermentations. b) Histogram showing product formation of serum bottle fermentation of deletion strains and complementations.
Glucose usage and product formation is shown after 24 h. Error-bars indicate standard error of three replicates.
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the production of metabolites derived from acetyl-CoA (butyrate,
ethanol and n-butanol) were largely unaﬀected, apart from a decrease
of acetate production to 9.7 mM at time point 24 h compared to 14 mM
in the WT, and an increase in lactic acid production (6.7 mM at time
point 48 h compared to 4.6 mM in the WT). The solvent proﬁles of
CRG5534 on glucose where as expected essentially the same as the WT
(Fig. S2). In the complemented strain, in which dhaBCE has been
integrated at pyrE together with its native promoter, production of
PDO was re-instated, although at a lower level than the WT. The lactate
and acetate proﬁles were very similar to that of the WT (Fig. S2).
4. Discussion
The use of pyrE alleles for gene knock-out forms part of a general
‘roadmap’ for manipulating bacterial genomes (for a review see Minton
et al., 2016), the implementation of which is reliant on eﬀective gene
transfer into the target organism. In the case of C. diﬃcile (Ng et al.,
2013) and G. thermoglucosidasius (Sheng et al., 2017) no special
measures were required to achieve this, whereas in C. acetobutylicum
the rational circumvention of host restriction barriers proved to be
necessary by appropriate methylation of the plasmid DNA being
transferred (Ehsaan et al., 2016). Here we showed that an alternative
approach is possible through the isolation of a highly transformable
variant of the C. pasteurianum strain DSM 525, strain CRG4111.
The reason for the increased competence of CRG4111 is unclear.
Neither of the two SNPs present are in genes with any obvious
association with restriction/ modiﬁcation. Both are destructive in
nature resulting in frame-shifts and premature termination of the
encoded proteins. Whether one or the other, or both, are responsible
for the phenotype is not immediately apparent. One gene encodes β-
lysine N6-acetyltransferase (ablB), which, being involved in lysine
degradation seems to have no connection with improved DNA transfer.
CLPA_c33080 encodes a histidine kinase (ResE9), but does not appear
to be part of a two-component system, as no gene encoding a cognate
response regulator was located in the immediate vicinity. Interestingly,
however, the gene (CLPA_c33090) immediately adjacent to the ResE9
encodes a homologue of an agr quorum sensing AgrB protein,
responsible for processing and secretion of the AgrD signal molecule.
Indeed, an unannotated ORF is present immediately downstream of
CLPA_c33090 encoding a 57 amino acid peptide that shares signiﬁcant
identity with clostridial AgrD signal peptides, including 58% with those
of Clostridium tetanomorphum DSM 665 (KAJ50110.1 and
KAJ51453.1), Clostridium scatologenes (AKA70070.1) and
Clostridium carboxidivorans P7 (EET84565.1) and 52% identity to
homologues in Clostridium botulinum (WP_061325181) and
Clostridium sporogenes (WP_053818607.1). All of these clostridial
species, and many more besides, share the same structural arrange-
ment of genes, corresponding to agrB > agrD > resE. This gene ar-
rangement, was ﬁrst noted in C. botulinum, where it was shown to be
involved in the regulation of sporulation and neurotoxin production
(Cooksley et al., 2010). The possibility exists that in C. pasteurianum at
least, this quorum sensing system also regulates a process that can
aﬀect the eﬃciency of DNA uptake.
Regardless of the mechanism responsible for increased compe-
tence, our ﬁndings have provided a further approach for maximising
DNA transfer rates which was used in combination with the developed
pyrE-based KO system to make a number of mutants (spo0A, hydA,
rex and dhaBCE) that inﬂuenced solvent production. A general work-
ﬂow and schematic for mutant generation is shown in Supplementary
Fig. S3. Signiﬁcantly we were able, for the ﬁrst time, to completely
eliminate PDO production in C. pasteurianum. The formation of PDO
from glycerol is mediated by the sequential action of glycerol dehy-
Fig. 6. Pure glycerol fermentations of C. pasteurianum-H1 (H1), C. pasteurianum-H1ΔdhaBCE (ΔdhaBCE) and C. pasteurianum-H1-dhaBCE complementation (dhaBCE*). Serum
bottle fermentation with 60 g/l glycerol in 2x YT medium was carried out for 48 h with fermentation being visibly completed after 24 h. * indicates statistical signiﬁcance of ΔdhaBCE
and ** of dhaBCE* in a t-test α > 0.05 against H1. Error-bars indicate standard error of three replicates.
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dratase (DhaBCE) and PDO dehydrogenase (DhaT). Here we chose to
entirely delete the dhaBCE region, and as a consequence generated a
strain which no longer produced PDO under all conditions tested.
Previous attempts to ablate the production of either glycerol dehydra-
tase or PDO dehydrogenase through the use of ClosTron technology
met with little success (Pyne et al., 2013). Intron mutants of dhaB,
dhaC and dhaE could not be isolated, whilst an intron insertion in
dhaT was obtained but the intron delivery plasmid and its encoded
LtrA protein could not be cured. Such a phenomenon can occur if the
intron insertion is in the sense strand of an essential gene, and LtrA-
mediated splicing of the transcribed mRNA provides a route for some
production of the encoded protein. However, the intron insertion in the
dhaT gene was in the antisense orientation. This led to the search for,
and apparent discovery of an additional ecotopic, sense strand, intron
insertion in speA (encoding arginine decarboxylase) which was hy-
pothesised as being essential. One consequence of these diﬃculties was
that Pyne et al. (2016) were unable to eliminate PDO production.
Glycerol is metabolized both oxidatively and reductively in
Clostridium (Malaviya et al., 2012). The pyruvate-generating oxidative
pathway leads to the production of CO2, H2, and electrons in the form
of the reducing equivalent NADH, which is also released during
biomass formation. Glycerol, being a highly reduced substrate, results
in twice the amount of reducing equivalents compared to using glucose
as fermentation substrate. These electrons require acceptors for redox
homeostasis, which is precisely the purpose of glycerol reducing
pathway producing the highly reduced product PDO. By deleting
dhaBCE in C. pasteurianum, the pathway for funnelling extra reducing
power during glycerol fermentation is absent, resulting in the poor
growth we observed in the mutant in deﬁned medium. The mutant was,
however, able to grow in a rich medium containing yeast extract. The
latter ingredient supports growth of the mutant by both providing an
alternative source of carbon and acting as a reducing agent. Re-
introducing dhaBCE back into the deletion mutant reversed the
phenotype, conﬁrming the production of PDO in C. pasteurianum is
important for biomass production and redox balance. Our ﬁndings
support the hypothesis of Johnson and Rehmann (2016), who found
that unlike C. acetobutylicum, C. pasteurianum glycerol fermentation
does not display strong biphasic behaviour, suggesting that PDO
production is regulated and further that its regulation may serve to
function in redox homeostasis and allow C. pasteurianum to behave in
a non-biphasic manner.
The Rex response regulator directly senses changes in the redox
status of the cell, having a much higher aﬃnity for NADH than for the
oxidised nucleotide NAD+ (Wang et al., 2008). Under oxic conditions
(i.e., when the NADH/NAD+ ratio is low) it binds to its target sites to
inhibit gene transcription but dissociates from these sites when the
NADH/NAD+ ratio increases (Brekasis and Paget, 2003). Thus, it was
expected that inactivation of Rex would lead to increased levels of those
enzymes whose genes were under Rex-mediated control, leading to a
consequent change in metabolic proﬁles. To predict such regulated
genes we used the procedure outlined in Materials and Methods to
search for potential Rex target sites in the genome. We identiﬁed a list
of 47 putative Rex box sequences which potentially
regulate the adjacent downstream genes (Supplementary Table S2)
and deﬁned a consensus sequence for C. pasteurianum, 5'-
TTGTTAAWNNNTTAACAA. Of the non-fermentative genes previously
reported, none were found using our approach (Ravcheev et al., 2012;
Zhang et al., 2014). However, other notable putative Rex targets found
include CLPA_c05450, a nitroreductase related to narAB or narK in C.
carboxidivorans (Zhang et al., 2014), CLPA_c09900, a nicotinamidase
family protein, CLPA_c17480 (spoVD2) encoding a stage V sporulation
protein and CLPA_c39090, a NADPH dehydrogenase.
Given that a high ratio of NADH/NAD+ inhibits binding of Rex to
DNA, it is expected that Rex-binding sites should be located upstream
of genes encoding NADH-dependent enzymes. This is true for the
alcohol dehydrogenases putatively involved in butanol and ethanol
production (adhE2 and its two alleles adhE1 and adhE4), indirectly the
thiolases that channel carbon into the reductive part of the fermenta-
tive pathway (thlA1 and thlA2), the crt-bcd-etfBA-hbd operon (croto-
nase-butyryl-CoA dehydrogenase-electron transfer ﬂavoprotein B/A-
hydroxybutyryl-CoA dehydrogenase) which uses 2 NADH to reduce
acetyl-CoA to butyryl-CoA, and the reductive part of the dha (glycerol
dehydratase) operon. In keeping with these observations, production of
ethanol and n-butanol was elevated in the rex mutant when grown on
either glycerol or glucose, as was demonstrated in C. acetobutylicum
(Wietzke and Bahl, 2012).
By the same reasoning, and based on observations made in C.
acetobutylicum (Ravcheev et al., 2012), we would have expected to ﬁnd
Rex sequences upstream of ldh (lactate dehydrogenase), hydA (hydro-
genase) and ptb-buk (phosphotransbutyrylase-butyrate kinase), as was
found in other species (Wietzke and Bahl, 2012; Hu et al., 2016), but
none were found, even with relaxed algorithm parameters.
Nevertheless, contrary to in silico expectations and the observations
made in C. acetobutylicum, the C. pasteurianum rex mutant produced
more lactate in glycerol fermentation compared to WT (Fig. 4). On the
other hand, as expected, butyrate production was signiﬁcantly reduced
in the absence of Rex, and a clear butyrate reassimilation in glycerol
fermentation was observed in the rex deletion mutant. Butyrate
assimilation has been shown in C. pasteurianum when feeding external
butyrate which led to increased butanol titres (Kao et al., 2013; Lin
et al., 2015; Sabra et al., 2014) but reassimilation of butyrate in a
standard fermentation was to our knowledge never observed before.
Some of the higher n-butanol titres observed in the mutant strain could
be explained by reassimilation and carbon recycling of butyrate.
Acetone formation was never observed in fermentations using the
C. pasteurianum WT, in agreement with Biebl (2001), Sandoval et al.
(2015) and Pyne et al. (2016). However, in the rex deletion mutant
butyrate is visibly reassimilated which in the pathway proposed by
Malaviya et al. (2012) is coupled to acetone formation via the
acetoacetyl- CoA: butyrate:CoA transferase in a similar fashion to C.
acetobutylicum (Jones and Woods, 1986). These ﬁndings suggest that
C. pasteurianummay be able to reassimilate butyrate without the need
of acetone production either through the reverse reaction of the
butyrate kinase (buk) and the phosphotransbutyrylase (ptb), as pre-
viously suggested (Hüsemann and Papoutsakis, 1989; Millat et al.,
2014), or via a third, as yet undescribed, mechanism proposed by
Millat et al. (2014). Reassimilation of butyrate without acetone
production has been described in several C. acetobutylicum inactiva-
tional mutants, most notably mutants of ctfA (Millat et al., 2014), ptb
(phosphotransbutrylase) and adc (acetoacetate decarboxylase)
(Lehmann et al., 2012) and butyrate kinase (buk) gene (Desai et al.,
1999). The fact that C. pasteurianum does not produce acetone under
any condition tested here, or elsewhere (Biebl, 2001; Pyne et al., 2016;
Sandoval et al., 2015), makes this organism an ideal target for
investigations of the butyrate and acetate uptake mechanisms not
reliant on CtfAB.
Since alcohol production competes for electrons with the formation
of molecular hydrogen, reducing the ﬂux of electrons towards H2
synthesis might be expected to increase n-butanol titres. Various
approaches have been reported that were designed to inhibit in vivo
hydrogenase activity, for example, by the application of artiﬁcial
electron carriers or sparging the culture with carbon monoxide
(Datta and Zeikus, 1985; Hüsemann and Papoutsakis, 1989; Kim
et al., 1984; Peguin et al., 1994;). The resultant increased NAD(P)H
availability, led to more n-butanol and ethanol and less acetone being
produced and a consequently improved alcohol: acetone ratio in C.
acetobutylicum. However, previous attempts to inactivate the gene
(hydA) encoding the major hydrogenase of C. acetobutylicum using the
ClosTron were unsuccessful (Cooksley et al., 2012), suggesting that the
gene is essential under the conditions tested. Whilst the C. pasteur-
ianum hydA gene (CLPA_ c00280) sharing the closest similarity to the
C. acetobutylicum hydA gene was recently knocked-down by Pyne et al.
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(2015) using an anti-sense approach, here we were able to generate a
null mutant through the deletion of the entire CLPA_c00280 encoding
gene.
In keeping with predictions, deletion of hydA led to increases in the
products of NADH-consuming pathways, with the mutant producing
2.7-fold higher levels of ethanol and 5-fold higher levels of lactate
(Fig. 4). In contrast, only a slight increase in n-butanol was observed
with the mutant generating only 1.1-fold higher levels than the WT.
Similar results were obtained with the knock-down mutant of Pyne
et al. (2015). Although not a NADH-consuming pathway, a signiﬁcant
increase (1.8-fold) in acetate levels was also seen. Both the acetate and
butyrate pathways generate ATP via substrate level phosphorylation.
One consequence of which was an increase in biomass attained by the
mutant (the mutant OD600 was 114% higher than the WT) and was
characterised by a shorter fermentation time as adjudged by the earlier
onset of increase in pH (after 18.7 h as opposed to 22.0 h in the WT).
The same observation was made by Pyne et al. (2015). This increase in
acetate production was not evident in the study of Dabrock et al.
(1992), who used CO to inhibit hydrogenase activity on glucose grown
C. pasteurianum. Here acetate production was reduced by almost 50%.
In this instance, however, all hydrogenase activity would have been
aﬀected. The mutant strain utilised in our study, and that of Pyne et al.
(2015), is only aﬀected in the production of HydA (CLPA_c00280).
Strain C. pasteurianum DSM 525 contains 3 more genes/ enzymes
(CLPA_c07060-70, CLPA_c33960 and CLPA_c37830) (Poehlein et al.,
2015) with homology to hydrogenase enzymes. With CLPA_c07060
and CLPA_c07070 C. pasteurianum seems to possess a rare [NiFe]-
hydrogenase with the genes encoding the small and large subunit,
respectively. The other gene encodes an iron only hydrogenase. All of
these proteins might compensate for the loss of HydA (CLPA_ c00280).
Unexpectedly, PDO production was signiﬁcantly reduced in the
hydA mutant, by 19% compared to the WT (Fig. 4). This is counter
intuitive as the PDO pathway is NADH-consuming. The study of Pyne
et al. (2016) also reported such a reduction in levels of PDO (in this
case 30%) in their knock-down mutant, while noting that PDO levels
can vary widely between fermentations – an observation also made in
other studies (Biebl, 2001, Taconi et al., 2009). Our data reinforces the
view that the reduction in PDO production that results from ablation of
hydA function is a real phenomenon. It should also be noted that the
reduction in PDO and accompanying increase in biomass is contrary to
suggestion of Biebl (2001) that the production of reducing equivalents
by biomass build up has to be equalled by production of PDO to
regenerate the pool of NAD+ to NADH.
5. Conclusion
In the current report we have developed and exempliﬁed a robust
tool kit for the metabolic engineering of C. pasteurianum based on the
use of pyrE alleles. To maximise gene transfer we deployed a novel
approach based on the isolation of a highly transformable variant
within the host population. In keeping with previous work on other
Gram-positive chassis, we once again showed the advantage of using a
pyrE minus strain as the host through the rapid complementation of
the deletion mutants by the integration of the complementing gene into
the genome at the pyrE locus concomitant with ACE-mediated
restoration of prototrophy. The system was used to make in-frame
deletion mutants of pivotal genes involved in solvent production,
namely hydA (hydrogenase), rex (Rex response regulator) and
dhaBCE (glycerol dehydratase). We were, for the ﬁrst time in C.
pasteurianum, able to eliminate PDO synthesis and demonstrate its
production was essential for growth on glycerol as a sole carbon source.
Inactivation of both rex and hydA resulted in increase in n-butanol
titres, representing the ﬁrst steps towards improving the utilisation of
C. pasteurianum as a chassis for the industrial production of this
important chemical.
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